Curanex Pharmaceuticals CURX Cash Flow Statement (2024-2025)

NASDAQ CURX
$5.27 +5.00 (+1,851.85%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2024 Dec2024 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.09M-0.28M-0.23M-1.19M-3.09M
Cash from Operations (Quarter) -0.13M-0.10M-9.19M-0.86M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.02M0.03M
Change in Working Capital
Change in Account Payables (Quarter) 0.11M-0.11M
Change in Accured Expenses (Quarter) 0.00M0.01M-0.00M0.00M
Other Working Capital Changes (Quarter) 0.05M0.03M
Financing Activities
Cash from Financing Activities (Quarter) 14.91M
Additional items
Change in Cash (Quarter) -0.13M-0.10M5.72M-0.86M
Free Cash Flow (Quarter) -0.13M-0.10M-9.19M-0.86M
Net Cash Flow (Quarter) -0.13M-0.10M5.72M-0.86M